Summary

A $492m memory bill caps cockpit launch upside: initiate at Hold, $83.87 target

InitiationBy Penmark Team
VCHold$83.87+2%
Page 1 of 27
Equity research | Initiation of coverage | United States
Automobiles & Auto Parts | Coverage: Initiated | Published 16 November 2026, 07:00 ET
Penmark Research Team | research@penmarkresearch.com
Visteon Corporation (NASDAQ: VC)

A $492m memory bill caps cockpit launch upside: initiate at Hold, $83.87 target

Rating
Initiation
Hold
12-month target
$83.87
Price, 13 Nov 26
$82.27
Price return
+1.9%
Total return
+3.8%
Bull case
$103.74
Bear case
$49.08

We initiate coverage on Visteon at Hold with an $83.87 12-month target, implying a +1.9% price return. Visteon supplies digital instrument clusters, cabin displays, domain controllers and electric-vehicle electronics to more than 30 original equipment manufacturer (OEM) partners. After third-quarter warranty charges of about $77m and a 22% one-year drop, today's share price already reflects a mid-cycle profit margin just above 11%.

  • Memory chip and printed circuit board (PCB) inflation of about $490m leaves nearly $50m unrecovered in 2027. At 90% cost pass-through, adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) sit nearly 7% below consensus, trimming value by about $1 per share.
  • Cabin displays and cockpit domain controllers (CDCs) drive +8.5% growth over market (GoM) in 2027 despite a 1% dip in customer car output. Growth over market measures how much faster Visteon's sales grow than vehicle production at its customers, before currency and pricing. Displays and CDCs reached nearly 28% of third-quarter sales, supported by Chery's high-performance cockpit (HPC) ramp and fourth-quarter launches with Geely and SAIC Motor.
  • Software reuse lifts mid-cycle EBITDA margin to 11.0%, slightly below what today's price implies and reducing value by nearly $2 per share. Reusing about three-quarters of CDC code alongside a best-cost footprint lowered engineering and selling, general and administrative (SG&A) costs from 2019 to 2025. Containing third-quarter warranty charges adds back about 60 cents per share.

What the market is missing. Consensus models near-full cost recovery without pass-through margin dilution. Billing chip inflation at zero profit lifts 2027 sales above the Street, yet leaves adjusted EBITDA nearly 7% lower and diluted earnings per share (EPS) almost a fifth lower.

Catalysts. February 2027 full-year results and cost-recovery guidance decide the call. Guiding to 98% recovery or $6bn of annual bookings adds more than $1 per share each. Planned Geely and SAIC Motor launches test cabin growth into mid-2027.

Valuation and target. Applying the peer-median 6.29x enterprise value (EV) to last twelve months (LTM) normalised EBITDA of about $333m yields our $80.23 base-case value. Discounted cash flow (DCF) at a 9.8% weighted average cost of capital (WACC) gives about $88 per share. Weighting our bull, base and bear cases rolls forward to our target.

Risks. Carmaker insourcing and Chinese rivals capping long-run cost recovery at 90% would cut about $8 per share. Mid-cycle margin reversion to the 10-year mean costs nearly $7 per share, while chip shortages remain a first-half 2027 risk.

Exhibit 1: Visteon trades at 4.6x FY27E adjusted EBITDA as sales reach $4,375m
FY end Dec, $mFY24AFY25AFY26EFY27EFY28E
Net sales3,8663,7683,8244,3754,626
Growth y/y−2.2%−2.5%+1.5%+14.4%+5.7%
Adjusted EBITDA474492386462537
Margin12.3%13.1%10.1%10.6%11.6%
Net income (GAAP)296201133189237
Diluted EPS ($)10.617.285.077.7310.58
Growth y/y−46.8%−31.4%−30.3%+52.5%+36.8%
Free cash flow29027774101251
At $82.27, 13 NovFY24AFY25AFY26EFY27EFY28E
P/E (diluted)7.8x11.3x16.2x10.6x7.8x
EV / Adj. EBITDA4.5x4.4x5.5x4.6x4.0x
P/B1.8x1.4x1.4x1.2x1.1x
FCF yield12.6%12.2%3.4%5.1%13.6%
Dividend yield0.0%0.7%1.8%1.9%2.0%
ROE24.1%12.8%9.1%12.5%15.1%
Net debt / Adj. EBITDA−0.6x−1.0x−0.6x−0.3x−0.2x
P/E at $83.87 target7.9x11.5x16.5x10.8x7.9x

Source: Company filings; Penmark Research estimates. Restated FY24A generally accepted accounting principles (GAAP) profit reflects a fourth-quarter 2025 deferred tax asset method change. Multiples show price-to-earnings (P/E), price-to-book (P/B), free cash flow (FCF) yield and return on equity (ROE) on bridge EV.

Skewed 0.65x upside-to-downside around our $80.23 base value keeps us at Hold

Exhibit 3: Scenario-weighted value of $77.14 rolls forward to our $83.87 target
$40$60$80$100$120Jan-26Jul-26Jan-27Jul-27ActualEstimatesPrice $82Bull $113 (+37%)Base $87 (+6%)Bear $53 (−35%)Target $84 (+2%)

Source: Signals; Yahoo Finance; Penmark Research estimates. Dashed fan lines show 12-month rolled scenario values from present values at right.

Scenarios and price target basis
Bull$103.74+26.1%20% prob.

Assumes 98% next-year cost recovery and a 12.0% mid-cycle margin on stronger cabin demand. Valued at the 7.26x peer upper-quartile multiple.

Base$80.23−2.5%55% prob.

Assumes 90% next-year recovery, full pass-through thereafter and an 11.0% mid-cycle margin. Valued at the peer-median multiple.

Bear$49.08−40.3%25% prob.

Assumes 75% next-year recovery, a 90% long-run cap and an extra warranty charge. Margin reverts to 10.3% at 4.84x.

12m target (from $77.14 weighted present value)$83.87+1.9% return = Hold
Upside / downside (present value)0.65x+$21.47 / −$33.19
Exhibit 4: Adjusted EBITDA rebounds from $386m in FY26E to $537m by FY28E
Income statement, $mFY24AFY25AFY26EFY27EFY28E
Net sales3,8663,7683,8244,3754,626
Adjusted EBITDA474492386462537
Depreciation & amort.(96)(109)(121)(130)(134)
SBC, restruct. & other(79)(62)(77)(65)(63)
Operating income299321188268340
Net interest & affiliates(1)171475
Income tax & NCI(2)(137)(69)(86)(108)
Net income (Visteon)296201133189237
Exhibit 5: Free cash flow dips to $74m in FY26E before reaching $251m
Cash flow, $mFY24AFY25AFY26EFY27EFY28E
Net income (incl. NCI)306213139198248
D&A and SBC137154168184192
Working cap., warr. & oth.(16)43(83)(123)(28)
Operating cash flow427410224259413
Capital expenditure(137)(133)(150)(158)(162)
Free cash flow29027774101251
Adjusted free cash flow300292100111256
Dividends & buybacks(63)(72)(274)(193)(242)
Exhibit 6: Balance-sheet policy holds $125m of net cash from FY27E onward
Balance sheet, $mFY24AFY25AFY26EFY27EFY28E
Cash & restricted cash626773549436421
Trade working cap., net356342356429439
PP&E and intangibles523746811839867
Other non-curr. & curr.8529851,0841,0841,084
Condensed assets2,3572,8462,8002,7882,811
Total debt319301326311296
Net cash307472223125125
Shareholders' equity1,2291,5681,4641,5141,567
Exhibit 7: Buybacks shrink diluted shares to 22.4m, lifting FY28E EPS to $10.58
Per share & KPIsFY24AFY25AFY26EFY27EFY28E
Weighted dil. shares (m)27.927.626.224.422.4
Adjusted EPS ($)n/r7.745.938.0410.74
Diluted EPS, GAAP ($)10.617.285.077.7310.58
Dividend per share ($)0.000.551.501.561.62
FCF per share ($)10.3910.042.834.1611.19
Book value / basic sh ($)45.0258.5159.2566.0675.54
Growth over market+4.0%+6.0%+5.5%+8.5%+7.5%
Cost recovery raten/an/a86.0%90.0%95.0%

Source: Company filings; Penmark Research estimates. Condensed assets net accounts payable inside trade working capital alongside property, plant and equipment (PP&E), while key performance indicators (KPIs) track cabin demand and recovery. Adjusted EBITDA excludes depreciation and amortisation (D&A), stock-based compensation (SBC), restructuring, tax, net interest, non-controlling interests (NCI) and affiliate income. Adjusted FCF adds back cash restructuring.

Unrecovered memory costs leave FY27E adjusted EBITDA 6.6% below consensus at $462.1m

Exhibit 8: Pass-through dilution compresses adjusted EBITDA margin to 10.1% before recovery
Growth & marginsFY24AFY25AFY26EFY27EFY28E
Growth y/y
Net sales−2.2%−2.5%+1.5%+14.4%+5.7%
Adjusted EBITDA+9.2%+3.8%−21.5%+19.7%+16.3%
Operating income+8.7%+7.4%−41.3%+42.0%+27.1%
Diluted EPS (GAAP)−46.8%−31.4%−30.3%+52.5%+36.8%
Dividend per sharen/an/a+172.7%+4.0%+4.0%
Margins & coverage
Underlying EBITDA mgn12.3%13.1%12.9%13.0%13.3%
Adjusted EBITDA mgn12.3%13.1%10.1%10.6%11.6%
Operating (EBIT) margin7.7%8.5%4.9%6.1%7.4%
Free cash flow margin7.5%7.4%1.9%2.3%5.4%
Adj. EBITDA / net int.n/m (net interest income)149.6x96.3x
Capex / net sales3.5%3.5%3.9%3.6%3.5%
Exhibit 9: Return on equity recovers from 9.1% in FY26E to 15.1% by FY28E
Returns & valuationFY24AFY25AFY26EFY27EFY28E
Returns & leverage
ROE (ending equity)24.1%12.8%9.1%12.5%15.1%
ROA (cond. assets)12.6%7.1%4.8%6.8%8.4%
ROCE (after-tax / IC)21.5%19.6%10.2%13.0%16.0%
Net debt / equity−25.0%−30.1%−15.2%−8.3%−8.0%
Net debt / Adj. EBITDA−0.6x−1.0x−0.6x−0.3x−0.2x
Valuation at $82.27 actual price
P/E (diluted GAAP)7.8x11.3x16.2x10.6x7.8x
EV / Adjusted EBITDA4.5x4.4x5.5x4.6x4.0x
P/B (basic)1.8x1.4x1.4x1.2x1.1x
FCF yield12.6%12.2%3.4%5.1%13.6%
Dividend yield0.0%0.7%1.8%1.9%2.0%
P/E at $83.87 target7.9x11.5x16.5x10.8x7.9x

Source: Company filings; Penmark Research estimates. Ratios cover earnings before interest and taxes (EBIT), return on assets (ROA) and return on capital employed (ROCE) over invested capital (IC). Net interest income turns to net expense in FY27E as surplus cash funds buybacks.

Exhibit 10: Zero-margin recoveries lift FY27E sales +2.4% above Street but cut EBITDA −6.6%
Penmark vs consensus4Q26EFY26EFY27EFY28E
Net sales ($m)
Penmark estimate9403,8244,3754,626
Consensus / guide9423,8264,2734,400*
Prior-year period9483,7683,8244,375
Diff. vs consensus / plan−0.2%−0.1%+2.4%+5.1%*
Growth y/y (Penmark)−0.8%+1.5%+14.4%+5.7%
Adjusted EBITDA ($m) & EPS ($)
Penmark Adj. EBITDA ($m)120.0386.0462.1537.3
Consensus / plan135.7401.7494.8590.0*
Diff. vs consensus / plan−11.6%−3.9%−6.6%−8.9%*
Penmark Diluted EPS ($)1.905.077.7310.58
Consensus EPS ($)2.185.359.57n/d
Diff. vs consensus EPS−12.8%−5.2%−19.2%n/d
EPS growth y/y (Penmark)−29.1%−30.3%+52.5%+36.8%

Source: Consensus snapshot (MarketScreener and S&P Capital IQ, 11 estimates, 23 Oct 2026); Penmark Research estimates. Fourth-quarter consensus is implied from full-year less nine-month actuals; *FY28E comparator is the Investor Day plan.

Exhibit 11: Visteon trades at 6.44x normalised trailing EBITDA versus the 6.29x peer median
LTM / 3Q26, 13 NovVCPeersDiff.
Valuation multiples
EV / norm. trailing EBITDA6.44x6.29x+2.5%
Forward P/E (FY27E Street)*8.60xn/dn/d
EV / LTM sales0.52x0.93x−44.6%
Price / book (3Q26)1.44x1.59x−9.4%
Margins, returns & growth
3Q26 revenue growth (y/y)+5.8%+0.4%+5.4pp
LTM EBITDA margin (rep.)7.8%12.8%−5.1pp
LTM EBITDA mgn (ex-warr.)9.8%12.8%−3.1pp
LTM ROIC11.4%15.4%−4.0pp
Trailing ROE10.9%12.7%−1.8pp

Source: Signals; Yahoo Finance; Penmark Research estimates (five-peer median: Gentex, Autoliv, Lear, PHINIA, Adient). Table shows return on invested capital (ROIC) and normalised EV on trailing EBITDA; *peer forward consensus is not in dataset.

Why a 4.6x forward headline multiple reconciles to Hold: Peer multiples are measured after stock-based compensation and normal restructuring, so we deduct about $77m of both from mid-cycle earnings. That puts Visteon at 6.44x normalised trailing EBITDA, slightly above the peer median and right in line with today's share price and our target.

February 2027 recovery guidance decides whether Visteon re-rates from 6.44x normalised EBITDA

Exhibit 12: February 2027 recovery guidance carries up to +$1.17 per share of upside
  • Feb 2027Results, chief financial officer (CFO) handoff and recovery guide: we model 90% cost pass-through, while 98% adds over $1 per share.
  • Feb 2027Annual bookings and warranty filing: reaching $6bn of awards adds about $1.60 per share, while the annual filing tests warranty containment.
  • 1H 2027China cockpit and dynamic random-access memory (DRAM) supply: Geely and SAIC Motor ramps test cabin growth worth nearly $1 per share on forward earnings.
  • FY27–Feb 28Underlying margin durability: quarterly results test whether underlying margin holds near 13% and supports an 11% mid-cycle floor.

Source: Q3 FY26 call; Penmark Research estimates.

Exhibit 13: Capped long-run cost recovery is the largest downside risk at −$8.33 per share
  • Chinese rivals and carmaker insourcing. Long-run cost recovery stays capped at 90% from 2029 onward. Prob. 25%; −$8.33/sh.
  • Margin reversion to cycle average. Cost savings fade back to the 10.3% historical average. Prob. 35%; −$6.72/sh.
  • First-half 2027 chip shortages and pushback. Customer car output drops 4% or recovery slows to 75%. Prob. 30–35%; up to −$2.76/sh.
  • Upside risk: durable 12% margin or lower cost of equity. Either shift lifts our target above $93 per share into Buy territory. Prob. 30%.

Source: Penmark Research estimates.

Exhibit 14: Unrecovered memory cost of −$49.2m pulls FY27E adjusted EBITDA to $462.1m
$0m$200m$400m$600mStreet FY27EUnderlyingbaseMemoryleakagePenmarkFY27E$494.8m+$16.5m−$49.2m$462.1m

Source: MarketScreener consensus (23 Oct 2026); Penmark Research estimates (13.0% underlying margin less fifth-generation double data rate (DDR5) and PCB leakage).

Exhibit 15: Visteon trades at 6.44x normalised trailing EBITDA against a 6.29x peer median
AutolivPHINIAVisteon (norm.)GentexLearAdient7.31x7.26x6.44x6.29x4.84x3.62x

Valuation anchor: The dashed line marks the five-peer trailing median (Gentex). Our bear and bull cases use the lower-quartile (Lear) and upper-quartile (PHINIA) peer multiples.

Source: Signals; Penmark Research estimates at 13 Nov 2026 (BorgWarner, Aptiv and Magna excluded).

Exhibit 16: Cost recovery outside 88%–93% next February breaks our Hold base case
IndicatorPenmark baseThesis confirmed (Hold)Upgrade / Buy triggerDowngrade / Sell trigger
FY27 cost recovery90% ($49.2m leak)88%–93% in Feb 2027 guide≥98% recovery & ≥$510m EBITDA≤75% recovery; OEM pushback
Growth over market+8.5% FY27E+7.5% to +9.0%; China HPC live≥+9.5% with $6.0bn+ FY26 wins≤+6.0%; China HPC slip
Underlying EBITDA mgn13.0% FY27E (11.0% mid)12.7%–13.2% ex-pass-through≥13.5% sustained (12.0% mid-cycle)≤11.5% (reversion toward 10.3%)
Warranty & CFO transition$0m extra FY27EQ3 $77m settled within accrualEarly permanent CFO; clean 10-K$20m+ additional warranty charge
What would change our view: Upgrading to Buy requires more than 10% upside, meaning a target above $90.50 at today's share price. Either a 1 percentage point drop in cost of equity, low-end beta or a 12% mid-cycle margin crosses that threshold. Downgrading to Sell requires a target below $74.04, triggered if capped recovery meets margin reversion.

Source: Penmark Research estimates.

Part I: Summary · 3. The thesis in charts

Today's share price already discounts an 11.2% mid-cycle margin, leaving +1.9% upside

Quarterly adjusted EBITDA margin moved with quarter-end share prices over the past eight quarters (correlation +0.62, directional only on eight observations). After the third-quarter warranty reset, today's share price already reflects near-mid-cycle profitability, leaving cost pass-through and discount rates as the main swing factors.

Exhibit 17: Third-quarter warranty charges knocked adjusted EBITDA margin down to 4.7%
Adj. EBITDA marginQuarter-end price (right)0%5%10%15%$70$80$90$100$110$1204Q241Q252Q253Q254Q251Q262Q263Q26

Lead driver: Excluding about $77m of warranty charges, third-quarter margin held near 13%, showing core operations remained intact.

Source: Company filings; Yahoo Finance; Penmark Research estimates.

Exhibit 18: Our $462.1m FY27E adjusted EBITDA estimate sits 6.6% below consensus
ConsensusInvestor Day objective$0m$200m$400m$600m$800mFY24AFY25AFY26EFY27EFY28EFY29EActualEstimates

Estimate gap: Recovering 90% of the chip bill leaves nearly $50m unrecovered, putting profit 11% below management's plan.

Source: Filings (A); Investor Day; Penmark Research estimates & consensus (E).

Exhibit 19: Priced margin and recovery optimism explain the −$2.04 gap to our $80.23 base
$0$20$40$60$80$100Share priceMid-cyclemarginFY27recoveryWarrantyBase value$82.27−$1.67−$0.97+$0.59$80.23

Price versus value: Market expectations for slightly higher margins and full pass-through outweigh our relief on warranty costs.

Source: Penmark Research estimates.

Exhibit 20: Third-quarter enterprise value compressed to $2,120m, just below 6x trailing EBITDA
Enterprise value8x LTM adj. EBITDA6x LTM adj. EBITDA4x LTM adj. EBITDA$1,000m$2,000m$3,000m$4,000m$5,000m2Q221Q234Q233Q242Q251Q26$2,120m$3,008m$2,256m$1,504m

Valuation context: Enterprise value now sits inside the lower historical multiple band, matching peers on normalised earnings.

Source: Signals; Yahoo Finance; Penmark Research estimates, actual quarterly LTM adjusted EBITDA (2Q22–3Q26).

Exhibit 21: A lower cost of equity or 12% margin lifts our target into Buy
Mid-cycle marginCost of equity (±1pt)Equity beta (1.10–1.50)FY27E cost recoveryBase $83.8710.3% $76.5712.0% $93.92+1pt $76.16−1pt (Buy) $93.611.50 $77.221.10 (Buy) $91.9675% $81.4998% $85.13

Source: Penmark Research estimates.

Exhibit 22: Our target sits well below the $95 to $135 Street target range
Bear $49Target $84Bull $104High $135Price $82Low $95Mean $112

Street lag: Consensus targets average about $112 despite recent cuts, well above our target and base-case value.

Source: MarketBeat consensus snapshot, 15 Nov 2026; Penmark Research estimates.

Low-conviction Hold and rating triggers: Our Hold call is low conviction because two of six valuation robustness tests flip the rating to Buy. Cutting cost of equity by 1 percentage point or using a 1.10 beta lifts our target above $91 per share. Proving a 12% mid-cycle margin also supports a Buy, while capped recovery plus margin reversion pulls value into Sell territory.
Part I: Summary · 4. Key debates

Three priced debates net to −$2.04 per share against today's $82.27 price

Today's share price implies an 11.2% mid-cycle margin, full long-run cost recovery and a lingering warranty discount. Replacing those three market views with ours reduces value by about $2 per share to our base-case value. Cockpit growth over market has zero weight in that trailing multiple gap and instead drives our multi-year cash flow forecast.

Exhibit 23: Three priced debates explain the −$2.04 per-share gap to our $80.23 base value
Key debateMarket / Street viewPenmark viewEvidence & $/sh impactWhat changes viewResolves
Mid-cycle underlying margin Price implies 11.22% ($81.89/sh); Investor Day targets 14.1% by FY29. 11.0% mid-cycle (13.0% FY27E normalising over the cycle). Platform reuse (~75% of CDC code) and a best-cost footprint lowered engineering and SG&A costs from FY19–25. −$1.67/sh Sustained ≥13.5% ex-recovery (+$9.25) or fade to 10.3% (−$6.72). FY27–Feb 28
FY27E memory & PCB recovery Street $494.8m adj. EBITDA (~near-100% pass-through; $81.20/sh). 90% FY27E recovery on $491.6m bill ($49.2m leak; $462.1m EBITDA). FY26 recovery ran ~86%; after the 2022 cost wave, margins rebuilt from 9.3% to 11.0% by FY23. −$0.97/sh Feb 2027 guide ≥98% (+$1.17/sh) or ≤75% (−$2.19/sh). Feb 2027
Warranty containment Post-Q3 sell-off prices ~$20m further warranty charge ($79.64/sh). $0m extra in FY27E base; $20m tail only in 25% bear case. Third-quarter filing calls $77m the best estimate for two warranty matters; extra $20m is not probable. +$0.59/sh Extra warranty charge ≥$20m in FY26 10-K (−$0.59/sh). Feb 2027
Cockpit GoM vs China & OEM mix Bulls extrapolate +10% Q3 GoM to $4.8bn FY29; bears fear China insourcing. +8.5% FY27E GoM on −1.0% output ($4,375m sales, +2.4% vs Street). 65 nine-month launches, $3.9bn wins and China HPC ramps. $0.00/sh in trailing gap (~$0.92/sh FY27E; $0.68/sh DCF per 1pt). FY26 wins ≥$6.0bn (+$1.60) or 90% long-run recovery cap (−$8.33). 4Q26–Jul 27

Source: Q3 FY26 Form 10-Q and earnings call; Investor Day 2026; Penmark Research estimates.

Exhibit 24: Replacing market expectations with ours pulls base value down by $2.04 to $80.23
Market-impliedPenmark Research estimatesMid-cycle marginMemory cost recoveryWarranty containment$80.23$81.89$80.23$81.20$79.64$80.23

Source: Penmark Research estimates. Three priced debates sum to −$2.04/sh.

Where each debate is tested in our thesis

  • Memory and board cost recovery: Tests fourth-generation double data rate (DDR4) end-of-life and board inflation against 90% pass-through and Street profit estimates.
  • Cockpit growth and China launches: Quantifies +8.5% 2027 growth over market from displays, domain controllers and China ramps despite lower car output.
  • Mid-cycle margin and warranty risk: Weighs software reuse supporting an 11.0% mid-cycle margin against third-quarter warranty containment.
Exhibit 25: Five dated milestones resolve the thesis between November 2026 and February 2028
Nov 2026CFO handoverMyers interim CFOQ4 2026China HPC launchesGeely and SAIC liveFeb 2027FY26 10-K & FY27 guideRecovery rate & bookingsJul 2027H1 FY27 printDDR4/PCB supply checkFeb 2028FY27 full-year printMid-cycle margin proof

Source: Form 8-K (27 Oct 2026); Q3 FY26 call; Penmark Research estimates.

Part II: The Business · 5. The story

Reuse 75% of the cockpit code, then haggle over a $490m memory bill

Visteon builds the digital screens and cabin computers inside cars for more than 30 OEM partners, turning a 2000 Ford spin-off into a nearly $3.8bn electronics specialist. Yet because carmaker orders carry no volume floor and chipmakers are retiring older memory, next year's profit hinges on passing through that cost wave.

26 yrsSpun off from Ford in 2000
30+ OEMsFord 26%; top three 48%
$3,768mFY25A net sales
~10,500Staff across ~17 countries
$2,081mDiluted market cap, 13 Nov

The scene

Last quarter, Visteon launched 21 new cabin products across 14 carmakers even as its customers built 5% fewer vehicles. Operating across 17 countries, Visteon designs digital instrument clusters, curved displays and SmartCore cabin computers for Ford, General Motors, Volkswagen, Geely and more than two dozen peers.

What it actually does

Old dashboards wired separate gauges and radios to dozens of small chips. Visteon merges them onto single glass panels run by one domain controller that handles safety gauges alongside entertainment and voice software. That shift lifts content per vehicle (CPV) from about $125 on basic clusters up to $1,000 on full-width displays.

How the money comes in

Carmakers pay per unit shipped under purchase orders with zero volume guarantees, and we assume a 1.5% annual drag from price-downs and foreign exchange (FX). Instrument clusters generate nearly half of sales, while displays, infotainment and domain controllers contribute almost another two-fifths. Every dollar of 2025 revenue left about 14 cents of gross profit and just over 7 cents of free cash flow.

Where the story turns

After shedding legacy climate and interiors, chief executive officer (CEO) Sachin Lawande rebuilt Visteon around reusable software, more than doubling adjusted EBITDA from 2019 to 2025. Late 2026 then brought two jolts. Third-quarter results carried about $77m of warranty charges, and memory makers began ending automotive DDR4 supply just as circuit boards tightened.

Why it works, and why it might not

Once certified inside a car platform, switching a cabin supplier mid-programme rarely pays, keeping launches compounding across 65 programmes in the first nine months of 2026. Pass-through friction and Chinese rivals are the catch: we assume 90% memory recovery next year and an 11.0% mid-cycle margin, leaving the shares fairly priced ahead of February 2027 guidance.

~75%SmartCore CDC code reuse
Reusing about three-quarters of CDC software alongside a best-cost footprint lowered engineering and overhead costs. Adjusted SG&A fell from 6.7% to 4.6% of sales between 2019 and 2025, while adjusted gross margin rose over three points.Source: 2026 Investor Day; Penmark Research estimates. Supports our 11.0% mid-cycle margin, slightly below what today's share price implies.
1 · HOW VISTEON WINS IT →
$3.9bnNine-month lifetime awards won via carmaker quotes.
2 · WHAT VISTEON SHIPS →
$125–$1kCabin CPV from basic clusters to pillar displays.
3 · WHAT CARMAKERS PAY →
−1.5%/yrPenmark price and FX assumption on purchase orders.
4 · WHAT VISTEON KEEPS
13.1¢ / 7.4¢FY25A adjusted EBITDA and FCF per $1 of sales.

Exhibit 26: One cabin programme from award to cash, keeping 7.4 cents of FCF per dollar of FY25A sales. Source: FY25 Form 10-K; Investor Day 2026; Signals; Penmark Research estimates.

Why the story matters for the stock: Consensus rewards Visteon's launch engine as if zero-margin chip recoveries were painless, while today's share price already discounts a mid-cycle margin above 11%. Our thesis pillars show why unrecovered chip inflation and mid-cycle normalisation keep us at Hold on our target.
Part II: The Business · 5. How Visteon makes money

Europe and North America generate 64% of Visteon's $3,768m annual sales

Visteon operates as a single Electronics segment across 17 countries, turning carmaker purchase orders into cabin hardware and software revenue. Net working capital (NWC) sits near 9% of sales, and 97% of manufacturing staff work in best-cost countries. That asset-light setup converts more than half of adjusted EBITDA into GAAP free cash flow.

Exhibit 27: European and North American carmakers generate 64% of $3,768m sales
Europe OEMs$1,277mN. America OEMs$1,149mRest of Asia & SA$767mChina OEMs$575mFY25A Net sales$3,768mClusters$1,747mInfotainment$508mDisplays$500mCockpit CDC$428mElectrification & other$585m

Regional revenue in the annual report nets $150m of inter-region eliminations against Asia and South America. China sales split roughly three-fifths domestic programmes and two-fifths export builds.

Source: FY25 Form 10-K, Note 20; Penmark Research estimates.

+10.0%3Q26 GoM (+3pp vs 4Q25)
$3.9bn9M26 new wins (vs $6bn goal)
65 launches9M26 programs (21 in 3Q26)
27.9%3Q26 Display + CDC mix (+4.7pp y/y)
13.1%FY25A Adj. EBITDA mgn (+80bp y/y)
Exhibit 28: Cost of sales leaves $532m of gross profit and $321m of operating profit
Clusters$1,747mInfotainment$508mDisplays$500mCockpit CDC$428mElectrif. & other$585mRevenue$3,768mCost of revenue$3,236mGross profit$532mSG&A$202mRestr. & other$9mOperating profit$321m

Source: FY25 Form 10-K; Signals; Penmark Research estimates. Cost of sales includes $220m of net engineering expense after customer reimbursements.

Fixed versus variable cost structure. Chips, display panels and circuit boards account for roughly 86% of revenue inside variable cost of sales. Reusing about three-quarters of CDC software alongside a best-cost plant footprint lowered engineering and overhead costs. Adjusted SG&A fell from 6.7% to 4.6% of sales since 2019, while adjusted gross margin rose more than three points.

Cash versus accounting profit. Last year, nearly $500m of adjusted EBITDA converted into $410m of operating cash flow and $277m of free cash flow. Capital spending absorbed 3.5% of sales. Across this year and next, third-quarter warranty payouts and pricier chip inventory temporarily compress annual free cash flow toward $75m to $100m.

Part II: The Business · 5. Revenue equation, product mix & customers

Customer cost recoveries and cabin launches lift FY27E sales 14.4% to $4,375m

Visteon's revenue splits into underlying cabin growth, net of price-downs and foreign exchange (FX), plus zero-margin component pass-throughs. Highlighted boxes in the revenue tree mark the two assumptions behind our gap to consensus: +8.5% growth over market and 90% recovery on next year's memory bill.

Exhibit 29: Underlying sales of $3,933m and $442m of recoveries build FY27E revenue
Customer output−1.0%Growth over mkt+8.5%Net price & FX−1.5%Underlying sales$3,933m (+5.8%)Cost wave$492m (12.5%)Recovery rate90.0%Cost recoveries$442mFY27E net sales$4,375m (+14.4%)

Source: Penmark Research estimates. Underlying FY26E base = $3,717m ($3,824m less $107m FY26E recoveries).

Exhibit 30: Instrument clusters and cabin displays generate 64% of $2,884m nine-month sales
ValueCumulative share (right)$0m$500m$1,000m$1,500m0%25%50%75%100%InstrumentclustersInformationdisplaysAudio &infotainmentCockpitdomain ctrl.Body &electrif.Other(incl. HUD)$476m$365m$301m$232m$143mTop 4: 87%

Nine-month display revenue rose 30% year on year to $476m, overtaking infotainment on multi-screen cabin launches.

Source: Q3 FY26 Form 10-Q; Penmark Research estimates. Clusters = $1,367m; other includes head-up display (HUD).

Exhibit 31: Ford, General Motors and Volkswagen generate 48% of annual sales
FordGeneral MotorsVolkswagen27+ other OEMs26%12%10%52%

Expanding business with Toyota, Honda, Geely, Chery, SAIC Motor, Tata and Mahindra spreads customer exposure across more than 30 OEM partners.

Source: FY25 Form 10-K, Item 1; Investor Day.

Purchase-order pricing and volume exposure. Carmaker awards run on purchase orders without minimum volume floors and often allow cancellation for convenience. We assume a 1.5% annual drag from net price-downs and currency. When Ford or General Motors trims electric schedules, Visteon feels immediate volume pressure, and chip surcharges must be agreed customer by customer.

Geographic and supplier concentration. Plant shipments are anchored in the United States and Portugal, which together generate roughly half of gross regional sales alongside China, India and Japan. On the supply side, concentrated automotive DRAM and high-layer circuit-board capacity drive next year's memory cost wave.

Valuation linkage: Each percentage-point move in 2027 growth over market is worth about $0.92 per share on next year's earnings, or $0.68 in our DCF, while leaving our trailing primary value unchanged. Each ten-point swing in 2027 cost recovery shifts adjusted EBITDA by nearly $50m, or about $1.45 per share in present value.
Part II: The Business · 6. The market

Cockpit consolidation lifts content per vehicle from $125 up to $1,000

Cabin electronics revenue grows through rising content per car rather than global vehicle output. Even as customer output fell 5% in the first nine months of 2026, larger liquid-crystal display (LCD) and organic light-emitting diode (OLED) screens kept Visteon outgrowing its markets.

Exhibit 32: Visteon sits between concentrated chipmakers and more than 30 carmaker buyers
Chips & memoryMicron, Qualcomm,Samsung~$500m FY27E cost wavePanels & PCBsOptical LCD/OLED,high-layer PCB2027 PCB tight supplyCockpit Tier-1Visteon, Aptiv, Bosch,Desay SV$3,768m sales; 13.1%FY25 marginSoftware & AISmartCore, CognitoAI,Android~75% CDC code reuseGlobal OEMsFord 26%, GM 12%, VW10%, GeelyPurchase orders, no volumefloorVisteon operating footprint

Source: FY25 Form 10-K; Q2 & Q3 FY26 calls; Investor Day.

Exhibit 33: Domain controllers and full-width screens lift cabin content up to $1,000
Low CPVHigh CPVEntry / discrete clusterMid-tier cockpit / displayConsolidated CDC / HPCPillar-to-pillar display$125$200$200$350$250$500$400$1,000

Merging clusters and infotainment onto one controller doubles compute value, while curved OLED and LCD panels reach $1,000.

Source: Visteon Investor Day presentation (25 Jun 2026).

Adjacent two-wheeler and commercial runway. Management sizes the two-wheeler market outside China at about 51m annual units. Connected thin-film transistor (TFT) screens are driving an 8.5% compound annual growth rate (CAGR) in India and Southeast Asia through 2029.

Exhibit 34: Third-quarter growth over market hit +10.0% despite a −5.0% output drop
Growth over marketCustomer production−5%0%+5%+10%1Q252Q253Q254Q251Q262Q263Q26+10.0%−5.0%

Customer car output is guided down about 6% in the fourth quarter. We then model a 1% dip in 2027 before modest growth resumes.

Source: Signals KPIs (1Q25–3Q26); Q3 FY26 deck.

Profit pool squeeze from memory and boards. Upstream chipmakers such as Micron, Samsung and SK Hynix are shifting wafer capacity toward artificial intelligence (AI) data-centre high-bandwidth memory (HBM) and fifth-generation double data rate (DDR5) chips, ending legacy automotive DDR4 production. Alongside tight multi-layer circuit boards, that shift creates roughly $490m of 2027 cost inflation and tests pass-through discipline.

Substitution and architecture shifts. Carmaker software insourcing and rapid iteration by domestic Chinese suppliers both cap long-run pricing power. Even so, management noted on the third-quarter call that memory redesign complexity is slowing new awards and prompting several Western carmakers to favour turnkey supplier platforms over full insourcing.

Cycle position and model view: Rather than assuming a sharp car production rebound, we model a 1% customer output drop in 2027 and 1% annual growth thereafter. Display and domain controller ramps carry revenue at +8.5% growth over market next year before moderating.
Part II: The Business · 7. Competitive position

Focused cockpit software helped Visteon grow third-quarter sales +5.8%, outpacing Western peers

Visteon competes as a focused cabin specialist against large diversified suppliers such as Aptiv, Bosch and Denso alongside fast-moving Chinese rivals led by Desay SV. That focus delivered nearly 6% third-quarter revenue growth, though smaller scale limits pricing leverage against carmakers.

Exhibit 35: Visteon grew third-quarter sales +5.8%, ahead of most Western auto suppliers
11.0%25.0%0.0%+1.5%−10.0%+30.0%Trailing EBITDA margin3Q26 revenue growth (y/y)Circle area: market cap ($bn)Defensive marginHigh growth & marginLaggingGrowth, compressed marginVCGentexAutolivLearPHINIAAdientAptivBorgWarnerMagnaDensoDesay SVValeoHyundai Mobis

Source: Yahoo Finance snapshot (13 Nov 2026); Signals. Ex-warranty VC LTM margin is 9.8% (FY25A adj. 13.1%).

Exhibit 36: Visteon leads peers on software reuse across six carmaker award criteria
VisteonGlobalTier-1sChinaTier-1sOEMin-housePlatform software reuseDisplay vertical integrationBest-cost country footprintChina domestic OEM speedMulti-year switching costsCost pass-through powerNoneWeakFairStrongLeading

Source: Penmark Research assessment from FY25 10-K, Investor Day and Q2–Q3 calls.

Where Visteon wins and cedes ground: In-house optical bonding and reusable software win global carmaker quotes. Faster domestic rivals keep China at roughly a tenth to a seventh of Visteon's sales mix depending on export attribution.

Exhibit 37: Instrument clusters and displays anchor 73% of sales against global rivals
Product line (FY25A)Primary named 10-K competitorsSubstitutes & structural threatVisteon position & moat durability
Instrument clusters ($1,747m, 46%)Denso, Continental, Bosch, Marelli, Nippon Seiki, ValeoConsolidation into a single central screenMature cash generator; multi-year vehicle certification plus two-wheeler growth in India and Southeast Asia.
Displays & infotainment ($1,008m, 27%)Harman (Samsung), LG Electronics, Panasonic, Alpine, BOECommodity panel assembly and smartphone projectionDisplay sales rose 30% in 9M26 on in-house optical bonding, backlighting and curved glass.
Cockpit CDC & AI ($428m, 11%)Aptiv, Bosch, Harman, Desay SV, Hyundai MobisCarmaker central compute and Chinese system-on-chip (SoC) kitsRoughly 75% SmartCore code reuse; Chery ramp and fourth-quarter Geely and SAIC Motor launches test China traction.
Body & electric power ($420m, 11%)BorgWarner, Valeo, Denso, LG, Hitachi AstemoDelayed Western electric launches and in-house battery packsWireless and wired battery management system (BMS) hardware; softened by slower Western electric builds.

Source: FY25 Form 10-K, Item 1 & Note 20; Q3 FY26 10-Q & call; Investor Day.

Valuation and margin implication: Because Visteon faces global giants and Chinese challengers without contractual volume floors, we fade underlying EBITDA margin from 13.0% next year to 11.0% at mid-cycle. That normalized profit base supports a multiple in line with the Western peer median.
Part II: The Business · 8. Management, governance and capital allocation

Visteon turned $1,410m of operating cash flow (OCF) since FY21 into $463m of buybacks

Since taking over in June 2015, Sachin Lawande has reshaped Visteon into a net-cash cockpit specialist, more than doubling adjusted EBITDA between 2021 and 2025. Board oversight is conventional, with an independent chair and seven independent directors. However, chief financial officer (CFO) Jerome Rouquet departs on 30 November 2026 just ahead of 2027 pass-through talks.

Exhibit 38: Officers and directors held 2.0% of shares in the April 2026 proxy disclosure
Executive / governance itemRole & statusPay & proxy ownership (Apr 15, 2026)Alignment & assessment
Sachin S. LawandePresident, CEO & Director (since Jun 2015)$12.88m FY25 target pay; 421,630 shares (1.6%) + 85,142 stock unitsLed cabin software pivot; roughly 76% of executive pay is at risk on EBITDA, FCF, ROIC and shareholder return.
Jerome J. Rouquet → Colleen E. MyersOutgoing CFO (leaves 30 Nov 26) → Interim CFO (Chief Acct. Officer)Rouquet $2.96m FY25 target; Myers base lifted to $330k + $25k monthly stipendFiling confirms no accounting or policy dispute; interim handover during warranty review and 2027 guide warrants watching.
Other executives & insider groupPynnonen (Legal), Vallance (Commercial), Trecker (HR)$1.60m–$1.90m target pay; all officers/directors held 532,254 sh (2.0%) + 239,339 unitsPre-scheduled Rule 10b5-1 sales in June 2026 (8,000 shares combined at $116.50–$120.00) executed near highs.
Board & pay metrics7 of 8 nominees independent; separate Chair since 2012Annual bonus: 40% Adj. EBITDA, 30% Adj. FCF, 30% goals. Long-term units: 50% ROIC, 50% relative returnRoughly 89% 2025 Say-on-Pay support; single-class common stock; independent audit committee oversight.

Source: 2026 proxy statement (DEF 14A filed 28 Apr 2026, latest proxy ownership as of 15 Apr 2026); Form 8-K (27 Oct 2026); Signals Form 4s.

Exhibit 39: Capital spending and $463m of buybacks absorbed 79% of cash flow since FY21
Operating cash flow$1,410mCash generated$1,410mCapex$649mShare buybacks$463mDebt paydown & M&A$212mDividends & FX/other$86m

Source: Signals cash flow statements; Investor Day; Penmark Research estimates (includes mergers and acquisitions (M&A) and FY21–9M FY26 buybacks).

Exhibit 40: Our $386m FY26E adjusted EBITDA estimate sits near the reset guidance midpoint
Penmark FY26EGuidanceConsensusPriorFY26E salesFY26E adj. EBITDAFY26E adj. FCF$3,824m vs guide $3,800m–$3,850m$386m vs guide $370m–$410m$100m vs guide $90m–$130m

Source: Q3 FY26 release; Investor Day 2026; Penmark Research estimates (Adjusted FCF basis; prior dot = June $475m EBITDA objective).

Capital return versus dilution. Share buybacks since 2021 have more than offset annual stock-based pay, shrinking diluted shares by roughly 3m since 2023. Management's multi-year plan targets about $1bn of adjusted free cash flow through 2029 alongside existing cash. Roughly 70% of that pool is earmarked for buybacks, with the rest split between dividends, debt and joint venture (JV) payouts.

Guidance track record. Four-year adjusted FCF of $842m beats the 2023 target of over $800m. However, it misses June 2026's outlook of more than $900m after third-quarter warranty charges forced an October guidance cut.

Part III: The Thesis · 9. What moves the stock

Margin resets sparked two-day drops of up to −12.8%, driving Visteon's stock moves

Across Visteon's last ten corporate events, the shares moved sharply whenever margin durability or cost pass-through shifted rather than on market beta. Broad S&P 500 moves explain only about 15% of weekly variance over five years, leaving more than two-fifths to company-specific news. Memory pass-through and cabin launches together drove nearly two-thirds of analyst questions on 2026 earnings calls.

Exhibit 41: Margin resets triggered sharp sell-offs of −12.8% and −10.0%
Q4 24 printQ1 25 printQ2 25 printQ3 25 printQ4 25 guideQ1 26 beatInvestor DayQ2 26 printQ3 26 warrantyCFO 8-K+7.2%+5.9%−0.8%−6.5%−12.5%+13.7%−12.8%+0.6%−10.0%−4.3%

Investor Day lesson: On 25 June 2026, management outlined multi-year sales and margin ambitions, yet the shares fell nearly 13% over two days. Investors discounted distant margin goals ahead of DDR5 cost inflation and Western electric-vehicle delays.

Source: Penmark analysis using Yahoo Finance daily closes around ten Visteon events (Feb 2025–Oct 2026).

Mid-cycle underlying margin

Confirmed by three of four tests. Shares fell nearly 13% on both Investor Day and fourth-quarter margin guidance. Our 11% mid-cycle margin sits nearly $1.70 per share below market-implied expectations. Next watch: Fourth-quarter adjusted margin near 13% against Street expectations above 14% in February 2027.

Memory and PCB cost recovery

Confirmed by three of four tests. Pass-through drove over a third of 2026 call questions. Our 90% recovery base sits about $1 per share below near-full Street pass-through. Next watch: February 2027 adjusted EBITDA guidance against our forecast of about $460m.

Cockpit growth over market and China launches

Confirmed by two of four tests. Shares jumped nearly 14% over two days on first-quarter launch strength. Each point of 2027 growth over market adds almost $1 per share on forward earnings. Next watch: Full-year bookings near $6bn and fourth-quarter Geely and SAIC Motor launches.

Warranty containment and CFO transition

Confirmed by two of four tests. Shares fell 10% on third-quarter warranty charges and over 4% on the finance chief filing. Zero extra 2027 charges add about $0.60 per share against market fears. Next watch: Annual filing warranty footnote and permanent finance chief appointment by February 2027.

Multi-year return and beta context

Visteon fell about 22% over one year and a third over five years as multiples compressed despite EBITDA more than doubling. Five-year weekly regression beta of 0.86 sits below our tested discount-rate range. Using that lower beta would imply a Buy rating, underscoring our low Hold conviction.

Candidates tested and dropped

Four common narratives failed our tests. Regional plants naturally hedge currency translation. Share buybacks since 2021 also dwarf the quarterly dividend initiated in 2025, while tax swings and headline car sales failed to explain event-day moves.

Part III: The Thesis · 10. Memory and PCB cost recovery

Unrecovered memory and board costs of $49.2m trim value by −$0.97 per share

The claim: Recovering 90% of next year's memory bill leaves adjusted EBITDA nearly 7% below consensus.
Exhibit 42: Component cost inflation peaks at $491.6m next year with 90% recovery
Cost inflation (E)Recovery rate (right, E)$0m$100m$200m$300m$400m$500m85%90%95%100%FY26EFY27EFY28EFY29EFY30E

Source: Q3 FY26 call; Penmark Research estimates (FY26E–30E).

What the market believes

Published consensus models nearly $495m of 2027 adjusted EBITDA, embedding fuller cost pass-through than our base case. Pricing near-full recovery next year implies about $81 per share against our base-case value. Solving today's share price for long-run pass-through alone separately implies recovery slightly above 100%.

Independent evidence

Earnings call sizing: Management sized next year's memory and electronics inflation near $500m on the third-quarter call. They aim to protect profit dollars rather than percentage margins. Recovery track record: Pass-through ran near 86% in 2026. After the 2022 cost wave, margins rebuilt from roughly 9% to 11% within a year. Contract structure: Carmaker purchase orders carry no automatic commodity escalators. Visteon must negotiate customer surcharges or redesign boards for newer DDR5 memory with suppliers such as Micron.

Exhibit 43: Pass-through dilution leaves next year's adjusted EBITDA at $462.1m versus $494.8m consensus
$m unless statedFY26EFY27E PenmarkFY27E StreetFY27E PlanFY28EFY29E
Underlying cockpit net sales3,717.13,932.9n/dn/d4,206.04,498.2
Gross component cost inflation124.3491.6n/dpre-shock441.6404.8
OEM pass-through recovery rate86.0%90.0%n/dn/a95.0%100.0%
Customer cost-recovery revenue (0% mgn)106.9442.4n/dn/a419.6404.8
Total net sales3,824.04,375.34,273.04,150.04,625.64,903.0
Unrecovered component leakage(17.4)(49.2)n/d0.0(22.1)0.0
Adjusted EBITDA386.0462.1494.8520.0537.3611.8
Reported Adj. EBITDA margin (vs 13.0% underlying FY27E)10.1%10.6%n/d12.5%11.6%12.5%

Source: MarketScreener and MarketBeat consensus; Investor Day 2026; Penmark Research estimates. Guiding to near-full recovery next year adds over $1 per share, whereas 75% recovery costs more than $2. A permanent 90% recovery cap would cut value by over $8 per share.

Dated signposts to watch: Initial 2027 adjusted EBITDA guidance at or above $500m in February would confirm near-full cost recovery. A guidance midpoint around $450m to $475m would back our base case instead. First-half gross margins in April and July will then show whether board bottlenecks push recovery down toward three-quarters.
Part III: The Thesis · 11. Cockpit growth over market and China HPC

Display and controller ramps drive +8.5% growth over market on −1.0% car output

The claim: Multi-screen display and domain controller ramps sustain +8.5% growth over market next year despite lower car production.
Exhibit 44: Displays and domain controllers climbed +4.7pp to 27.9% of third-quarter sales
0%20%40%60%80%100%1Q252Q253Q254Q251Q262Q263Q26ClustersDisplaysCockpit CDCInfotainmentBody & electrif.Other / HUD

Source: Q3 FY26 Form 10-Q & FY25 Form 10-K product-line tables.

Exhibit 45: Sixty-five product launches drove +10.0% third-quarter growth over market
Wins ($bn)3Q26: $0.9bn1Q263Q26Launches3Q26: 211Q263Q26GoM (%)3Q26: +10%1Q263Q26Output (%)3Q26: −5%1Q263Q26

Source: Signals quarterly KPIs (1Q26–3Q26).

What the market believes

Consensus models nearly $4.3bn of 2027 revenue, under-counting zero-margin cost recoveries while doubting China momentum. Bulls instead extrapolate recent launch growth straight toward management's $4.8bn sales ambition for 2029. That bullish view ignores award delays as carmakers redesign older memory boards.

Independent evidence

Quarterly launch cadence: Visteon launched 65 new products across the first nine months of 2026. Growth over market accelerated to 10% in the third quarter even as customer car builds fell 4% to 5%.

Product-line mix shift: Nine-month cabin display revenue jumped 30% year on year to nearly $480m. European sales also rose almost a fifth in the third quarter, offsetting softer battery-management demand on delayed Western electric models.

China ramps and bookings: Chery's high-performance controller is ramping in production, with Geely and SAIC Motor launches slated for the fourth quarter. Nine-month awards reached almost $4bn despite memory-related quote delays.

What it is worth

Our growth-over-market forecast lifts next year's underlying sales nearly 6% to about $3.9bn, or $4.4bn with cost recoveries. Each percentage point of 2027 growth over market is worth about $0.92 per share on next year's earnings, or roughly $0.68 in our DCF. Our primary trailing valuation does not move directly, while each point of customer car output shifts DCF value by about $0.74 per share.

Dated signposts to watch: Watch for on-time production starts across planned Geely and SAIC Motor cockpit programmes in China through early 2027. Full-year bookings near $6bn in February would confirm commercial momentum. Second-quarter results in July will test whether chip shortages push customer car output down toward −4%.
Part III: The Thesis · 12. Mid-cycle margin and warranty containment

Software reuse supports an 11.0% mid-cycle margin, trimming −$1.67 per share versus price

The claim: Reusable cabin software lifts Visteon's mid-cycle underlying EBITDA margin to 11%.
Exhibit 46: Underlying EBITDA margin normalises from a 13.6% peak to 11.0% at mid-cycle
Adj. EBITDA marginUnderlying margin6%8%10%12%14%FY16AFY19AFY22AFY25AFY28EFY31EFY34EActualEstimates10.1%11.0%Price-implied 11.2%FY16–25 avg 10.3%

Source: Company filings (FY16A–25A); Penmark Research estimates (FY26E–35E).

What the market believes

Today's share price implies a mid-cycle margin just above 11%. It also prices roughly $20m of further warranty charges. Bulls point to management's 14% margin ambition for 2029, whereas bears expect reversion toward the 10% historical average.

Independent evidence

Reuse and footprint: Reusing about three-quarters of CDC software alongside a best-cost footprint lowered engineering and overhead costs. Overhead fell by two points of sales and gross margin rose over three points since 2019, helping lift EBITDA margin by more than five points across several drivers. Cycle record: Ten-year adjusted EBITDA margin averaged just over 10%, supporting mid-cycle normalisation down to 11% (customer price-downs are already in sales growth). Warranty filing: Management accrued $77m across two warranty matters, with up to $20m extra reasonably possible rather than probable.

Exhibit 47: Underlying EBITDA margin rose 5.2pp before normalising to 11.0% at mid-cycle
Margin & cost structureFY19AFY21AFY23AFY25AFY27EFY29EFY35E
Net sales ($m)2,9452,7733,9543,7684,3754,9035,842
Adjusted SG&A / net sales6.7%6.4%4.9%4.6%n/mn/mn/m
Underlying EBITDA margin (ex-pass-through)7.9%8.2%11.0%13.1%13.0%13.6%11.0%
Reported Adjusted EBITDA margin7.9%8.2%11.0%13.1%10.6%12.5%10.1%

Source: Investor Day 2026; Signals; Penmark Research estimates (SG&A is not forecast separately).

Exhibit 48: Priced margin optimism (−$1.67) outweighs warranty relief (+$0.59) per share
Valuation leverMarket-impliedPenmark baseGap vs priceBull caseBear case
Mid-cycle underlying EBITDA margin11.22% ($81.89)11.0% ($80.23)−$1.67/sh12.0% (+$9.25/sh)10.3% (−$6.72/sh)
Incremental warranty accrual (pre-tax)~$20m ($79.64)$0m ($80.23)+$0.59/sh$0m ($0.00/sh)$20m (−$0.59/sh)

Source: Penmark Research estimates.

Dated signposts to watch: The annual warranty footnote in February 2027 will show whether third-quarter charges remain contained without an extra provision. Sustaining underlying margins above 13% through early 2028 would support a 12% bull case. A slide below 12% would revive reversion risk instead.
Part IV: The Numbers · 13. Track record and quality of reported numbers

Stock compensation of $45m and $77m of warranty charges require earnings normalisation

Five-year results paired genuine cabin software leverage with one-off tax, warranty and pass-through noise. Annual sales rose by more than a third since 2021 to nearly $3.8bn as adjusted EBITDA more than doubled. Company-defined adjusted EBITDA excludes non-cash SBC while absorbing exceptional third-quarter warranty charges. Our valuation deducts trailing SBC and normal restructuring from earnings, and treats after-tax warranty accruals as a debt-like claim.

Exhibit 49: A $330m tax benefit lifted GAAP profit above $434m adjusted EBITDA
Adjusted EBITDAGAAP net income$0m$200m$400m$600mFY21AFY22AFY23AFY24AFY25A

Source: Investor Day 2026 (restated for deferred tax asset (DTA) accounting change); Penmark Research estimates.

Exhibit 50: Adjusted FCF conversion climbed from a 9.6% trough to 59.3%
Adjusted FCFAdj. FCF / Adj. EBITDA (right)$0m$100m$200m$300m0%20%40%60%80%FY21AFY22AFY23AFY24AFY25A

Source: Investor Day 2026; FY25 Form 10-K; Penmark Research estimates.

Exhibit 51: Stock pay rose to 9.1% of annual adjusted EBITDA as warranty reserves hit $192m
$m (except % & ratios)FY21AFY22AFY23AFY24AFY25A9M FY26A
Earnings bridge & margin quality
Net sales2,7733,7563,9543,8663,7682,884
GAAP net income attributable to Visteon*4112456829620185
Provision / (benefit) for income taxes3145(330)(8)12543
Depreciation and amortisation1081081049610989
Non-cash stock-based compensation182634414535
Restructuring, impairment & net other items304558491214
Company-defined Adjusted EBITDA228348434474492266
Memo: Standardized reported EBITDA (Signals)n/dn/dn/d364448n/d
SBC as % of Adjusted EBITDA7.9%7.5%7.8%8.6%9.1%13.2%
Cash conversion & warranty accruals
GAAP operating cash flow / GAAP FCF58 / (12)167 / 86267 / 142427 / 290410 / 27781 / (22)
Adjusted free cash flow (adds restructuring cash)22101150300292(4)
Product warranty & recall accrual (10-Q line, period end)n/dn/dn/dn/d107192

*Prior GAAP net income restated for the 2025 DTA method change ($274m pre-restatement for FY24A). Source: FY25 Form 10-K; Q3 FY26 Form 10-Q; Signals; Penmark Research estimates.

Growth split: pass-through vs mix

Annual sales growth swung from over 35% during chip surcharges to slightly negative on routine price-downs. Electric-vehicle delays slowed battery demand in North America and China. Display and controller launches still lifted gross margin over three points since 2019 and helped expand EBITDA margin over five points across several drivers.

Accounting choices & cash conversion

Excluding SBC, netting research and development (R&D) recoveries and accruing warranties shape reported earnings. Non-cash SBC more than doubled to nearly a tenth of adjusted EBITDA, while customer engineering recoveries reduce cost of sales directly. Third-quarter warranty charges and chip buffer stocks pushed nine-month adjusted FCF slightly negative.

Part IV: The Numbers · 14. Forecasts: revenue, margins and consensus

Zero-margin surcharges lift next year's sales 14.4% to $4,375m while diluting reported margins

Our ten-year forecast separates core cabin demand from zero-margin memory and circuit-board surcharges. Underlying sales grow as cabin launches more than offset flat car production and our assumed 1.5% annual drag from price-downs and currency. Recovering most of next year's memory bill lifts headline revenue to nearly $4.4bn. Unrecovered chip costs hold next year's adjusted EBITDA near $460m before underlying margins normalise at mid-cycle.

Exhibit 52: Underlying EBITDA peaks at $619m before normalising to an 11.0% mid-cycle margin
$m (except % & per-share)FY25AFY26EFY27EFY28EFY29EFY30EFY35E
Revenue equation & component cost recoveries
Growth over Market (ex-output & pricing)*n/rn/m+8.5%+7.5%+7.5%+5.0%+3.0%
Underlying sales (ex-new-wave recoveries)*3,7683,7173,9334,2064,4984,6995,360
Component cost inflation ($m / recovery %)0124 (86%)492 (90%)442 (95%)405 (100%)423 (100%)482 (100%)
Component cost recoveries in sales0107442420405423482
Reported Net sales3,7683,8244,3754,6264,9035,1225,842
Reported Net sales growth−2.5%+1.5%+14.4%+5.7%+6.0%+4.5%+2.5%
Margin structure, GAAP EBIT & EPS
Underlying EBITDA (ex-pass-through & warranty)492480511559612619590
Underlying EBITDA margin (% underlying sales)13.1%12.9%13.0%13.3%13.6%13.2%11.0%
Unrecovered chip cost & Q3 warranty charges0(94)(49)(22)000
Company-defined Adjusted EBITDA492386462537612619590
Reported Adjusted EBITDA margin13.1%10.1%10.6%11.6%12.5%12.1%10.1%
GAAP operating income (after D&A, SBC, restr.)321188268340407370304
GAAP Diluted EPS / Adjusted EPS ($)**7.28 / 7.745.07 / 5.937.73 / 8.0410.58 / 10.7414.11 / 14.3014.58 / 16.34n/m**

*Assumes customer output of −1.0% in FY27E and +1.0% thereafter, plus −1.5% annual net pricing and FX; FY26E −$94m combines −$17.4m chip leakage and −$77.0m warranty charges. **FY35E per-share omitted due to mechanical $125m net-cash buyback sweep. Source: Penmark Research estimates.

Exhibit 53: Our forecasts sit 2.4% above next year's sales consensus but 6.6% below on adjusted EBITDA
Metric & periodGuide / Plan*ConsensusPenmarkGap & analytical driver
FY26E Net sales ($m)3,800–3,8503,8263,824−0.1% vs Street; inside guide (9M $2,884m + Q4 ~$940m)
FY26E Adjusted EBITDA ($m)370–410401.7386.0−3.9% vs Street; inside Oct reset ($77m warranty, 86% recov.)
FY26E Adjusted FCF ($m)90–130n/d100.3Inside guide; $150m capex & +$59.4m Q4 NWC release
FY27E Net sales ($m)4,150 (plan)4,2734,375.3+2.4% vs Street / +5.4% vs plan; $442.4m chip pass-through
FY27E Adjusted EBITDA ($m)520 (plan)494.8462.1−6.6% vs Street / −11.1% vs plan; $49.2m unrecovered cost
FY27E Diluted EPS ($)n/d9.577.73−19.2% vs Street (Adj. $8.04); lower EBITDA & tax/D&A/sh.
FY26E–29E Cum. Adj. FCF ($m)~1,000 (plan)n/d776.4−22.4% vs plan; lower EBITDA, $77m warranty cash & NWC

*FY26E shows 22 Oct 2026 formal guidance; FY27E–29E plan shows 25 Jun 2026 Investor Day objectives; consensus per MarketScreener (23 Oct 2026).

Key forecast takeaway: Zero-margin surcharges lift headline sales well above management's multi-year Investor Day targets. Unrecovered chip costs simultaneously keep adjusted EBITDA roughly a tenth below those targets over the next two years.
Part IV: The Numbers · 14. Forecasts: cash flow, balance sheet and sensitivities

Three-year operating cash flow of $1,142m funds $617m of share buybacks after working-capital drags

Cash conversion dips through next year on surcharge receivables and warranty payouts before rebounding from 2028. Working capital tied up in pass-through billings and cash warranty settlements hold next year's FCF near $100m. Annual FCF then rebounds above $250m from 2028, sweeping surplus cash above a $125m net-cash floor into buybacks.

Exhibit 54: Operating cash flow of $1,142m funds capital spending and $617m of buybacks
$0m$500m$1000m$1500m$2000mFY26Eend cashFY27–29EOCFCapexDividends& NCIDebtpaydownSharebuybacksFY29Eend cash$549m+$1142m−$486m−$137m−$45m−$617m$406m

Source: Penmark Research estimates (cash incl. $2m restricted).

Exhibit 55: DCF value spans $85.35 to $91.00 across next year's output and GoM
$85.35$86.01$86.67$87.33$87.99$86.07$86.74$87.41$88.08$88.74$86.80$87.47$88.15$88.82$89.50$87.52$88.21$88.89$89.57$90.25$88.25$88.94$89.63$90.32$91.00FY27E growth over market6.5%7.5%8.5%9.5%10.5%FY27E output−3.0%−2.0%−1.0%0.0%+1.0%
80% recov.$86.43
85% recov.$87.29
90% base$88.15
95% recov.$89.01
100% recov.$89.87

Source: Penmark Research estimates (other inputs at base).

Fixed vs variable cost structure

Chips, screens and circuit boards make roughly 85% of cost of sales variable, while R&D and overhead stay largely fixed. Reusing about three-quarters of CDC software alongside a best-cost footprint lowered engineering and overhead costs. Overhead fell two points of sales and gross margin rose over three points since 2019, before underlying margins normalise to 11% at mid-cycle.

Working capital, warranty & capex

Surcharge receivables and warranty payouts weigh on cash before normalising in 2028. Next year absorbs roughly $73m of working capital on pass-through billings alongside $50m of cash warranty settlements. Capital expenditure stays disciplined near 3.5% of sales throughout our forecast.

Balance sheet & buyback mechanics

Our $125m minimum net-cash floor sweeps surplus cash into share repurchases. Steady cash generation funds over $600m of buybacks across 2027 to 2029, retiring roughly a quarter of diluted shares under existing board authorisation. Visteon simultaneously pays down $15m of debt a year and grows its dividend 4% annually.

EPS gap vs Street & driver sensitivities

Our forecast of $7.73 in 2027 GAAP EPS sits $1.84 below published consensus. Lower EBITDA explains nearly $1 of that gap after tax, while unpublished Street tax, D&A and share-count assumptions explain the rest. Every five-point swing in next year's cost recovery shifts EBITDA by about $25m and DCF value by nearly $0.90 per share.

Why near-term shocks barely move our DCF: Single-year swings in 2027 chip recovery or car production shift full-cycle DCF value by less than 3%. Permanent changes in long-run pass-through or mid-cycle margins move equity value by $8 to $9 per share instead.
Part IV: The Numbers · 15. Valuation: primary mid-cycle multiple and range

Mid-cycle valuation of $80.23 and DCF of $88.15 bracket our target price

We value Visteon primarily on peer-median enterprise value to trailing EBITDA applied to normalised mid-cycle earnings, cross-checked by a ten-year DCF. Applying an 11% mid-cycle margin to trailing underlying sales avoids capitalising peak launch margins or one-year chip leakage. Deducting trailing SBC and normal restructuring aligns Visteon with our five-peer US supplier median, excluding peers distorted by impairments, spin-offs or International Financial Reporting Standards (IFRS) differences. Full-cycle DCF sits nearly 10% higher because it captures strong launch cash flows over the next five years before margins fade.

Exhibit 56: Applying the 6.29x peer median to normalised EBITDA yields our $80.23 base value
Primary mid-cycle valuation buildValue30 Sep 2026 bridge & trading multiplesValue
LTM underlying sales (to 30 Sep 2026, $m)3,724.9Cash & equivalents ($464m) less debt (−$330m)+134.0
Mid-cycle underlying EBITDA margin (%)11.0%Non-controlling interests (higher of multiple / JV cash)(90.0)
Mid-cycle underlying EBITDA ($m)409.7Employee benefit obligations (−$76m) + affiliates (+$29m)(47.0)
Less: LTM SBC (−$46.0m) & normal restr. (−$31.2m)(77.2)Accrued Q3 warranty liability, after 25% tax ($77m × 0.75)(57.8)
Normalized EBITDA, reported basis ($m)332.6Net claims in EV-to-equity bridge ($m)(60.8)
Target peer-median EV / LTM EBITDA (x)6.29xEV / normalized EBITDA at $82.27 price | at $83.87 target6.44x | 6.56x
Enterprise value ($2,090.5m) + net claims (−$60.8m)2,029.8EV / FY27E Adj. EBITDA at $82.27 price4.6x
Primary base value / share (25.3m diluted sh.)$80.23FY27E GAAP P/E at $82.27 price | at $83.87 target10.6x | 10.8x

Source: Q3 FY26 Form 10-Q; Signals peer metrics; Penmark Research estimates.

Exhibit 57: Net claims of −$60.8m bridge enterprise value to $2,029.8m of equity
$0m$500m$1,000m$1,500m$2,000m$2,500mEVNet cashNCI & JVPens. &affil.WarrantyEquity$2,091m+$134m−$90m−$47m−$58m$2,030m

Source: Penmark Research estimates (30 Sep 2026 balance sheet).

Exhibit 58: Primary value spans $59.30 to $104.10 across mid-cycle margin and multiple
$59.30$65.14$70.97$76.81$82.65$63.19$69.40$75.60$81.81$88.01$67.08$73.66$80.23$86.80$93.37$70.97$77.91$84.86$91.80$98.74$74.86$82.17$89.48$96.79$104.10Target EV / LTM EBITDA5.29x5.79x6.29x6.79x7.29xMid-cycle margin10.0%10.5%11.0%11.5%12.0%
Sensitivity slope: Half a point of mid-cycle margin shifts base value by over $4.60 per share. Half a turn of multiple shifts value by about $6.60 per share.

Source: Penmark Research estimates.

Exhibit 59: Primary and DCF ranges bracket the $82.27 share price and $83.87 target
Mid-cycle EV/EBITDA (bear–bull)Full-cycle DCF (bear–bull)12m target, Ke ±1pt12m target, beta 1.10–1.50Street 12m targets (11 est.)$25$50$75$100$125$150$49$104$53$106$76$94$77$92$95$135Price $82Target $84

Source: Penmark Research estimates (Ke = cost of equity); Street targets per MarketBeat and MarketScreener.

Part IV: The Numbers · 15. Valuation: full-cycle DCF, reverse DCF and target reconciliation

Rolling our $77.14 weighted value forward yields our $83.87 target and Hold call

Our ten-year DCF values Visteon at about $88 per share by discounting future cash flows to present value (PV). WACC is the blended annual return that debt and equity investors require to fund the business, estimated near 9.8% on a 1.30 published beta. Terminal growth is the steady annual rate at which cash flows grow forever after our explicit ten-year forecast, set at 2.5%.

Exhibit 60: Ten-year DCF cross-check values Visteon at $88.15 per share on 9.78% WACC
$m (except per-share & factors)4Q26EFY27EFY28EFY29EFY30EFY32EFY35ETerminal
Adj. EBITDA excl. specific warranty120.0462.1537.3611.8618.7612.7589.6n/a
Less: SBC, restructuring & D&A(51.6)(194.5)(197.0)(204.9)(248.8)(263.7)(285.4)n/a
EBIT / NOPAT (after 28% tax)68 / 49268 / 193340 / 245407 / 293370 / 266349 / 251304 / 219224.5*
Plus D&A, less capex & Δ trade NWC+44.2(100.9)(38.3)(54.4)(46.6)(39.9)(41.3)(46.8)*
Unlevered free cash flow93.591.8206.7238.5219.7211.4177.7177.7
Present value at 9.78% WACC92.485.6175.6184.5154.8123.678.61,030.7
DCF equity bridge & per-share valueExplicit PV $1,233.2m + terminal PV $1,030.7m = EV $2,263.9m − claims $60.8m = $2,203.2m ($87.08 → $88.15 at 13 Nov)

*Terminal column shows FY36E net operating profit after tax (NOPAT) of $224.5m less 20.8% reinvestment at 12.0% return on new invested capital (RONIC), discounted 9.25 years. WACC blends 10.61% Ke (5.10% risk-free rate, 4.24% equity risk premium, 1.30 beta) and 4.50% after-tax debt cost. Source: Penmark Research estimates.

Exhibit 61: Full-cycle DCF reaches $88.15 at our 9.78% base WACC
$112.79$115.26$118.17$121.66$125.91$97.90$99.26$100.81$102.60$104.70$86.59$87.33$88.15$89.06$90.10$77.71$78.08$78.49$78.93$79.41$70.54$70.70$70.87$71.04$71.21Terminal growth1.5%2.0%2.5%3.0%3.5%WACC7.78%8.78%9.78%10.78%11.78%

Source: Penmark Research estimates.

Exhibit 62: Downside weighting pulls present value to $77.14
Bear (25%)$49.08Base (55%)$80.23Bull (20%)$103.74Weighted PV$77.1412m target$83.87 (+1.9%)

Source: Penmark Research estimates.

Reverse DCF: A reverse DCF solves for the growth or margin assumptions needed to justify today's share price. Today's price implies a mid-cycle margin just above 11%, or perpetual cash flow decline near 3% a year at our discount rate.
Exhibit 63: Scenario synthesis yields an $83.87 target and +1.9% price return
Scenario & weight*Key operating assumptionsMargin / Mult.FY27E EBITDAPrimary PVDCF PV12m targetReturn / Call
Bear case (25%)75% recov. (90% end); −4% out; +$20m warr.10.3% / 4.84x$284.6m$49.08$53.05$53.35−35.1% (Sell)
Base case (55%)90% recov. (100% end); −1% out; +8.5% GoM11.0% / 6.29x$462.1m$80.23$88.15$87.22+6.0% (Hold)
Bull case (20%)98% recov. (100% end); +1% out; +9.5% GoM12.0% / 7.26x$532.5m$103.74$105.69$112.78+37.1% (Buy)
Weighted targetPV $77.14 × (1 + 10.61% Ke − 1.90% yield)6.56x norm.n/a$77.14$82.88$83.87+1.9% (Hold)
Robustness flips (2 of 6)Ke −1pt (7.03x justified mult.) → $93.61 (+13.8%, Buy); Beta 1.10 → $91.96 (+11.8%, Buy); Ke +1pt → $76.16 (−7.4%, Hold)

*Scenario probabilities are subjective analyst weights rather than statistical frequencies. Rating follows 12-month price return to our target (+1.9%, inside the −10% to +10% Hold band), excluding dividend yield (+3.8% total return). Source: Penmark Research estimates.

Part IV: The Numbers · 16. Catalysts

February 2027 guidance tests our Hold call as margin swings reach +$9.25 per share

Seven dated company and industry milestones over the next fifteen months test each operating driver of our thesis. Crossing into Buy requires catalysts that lift our target above $90.50, or a share pullback below $76.24 with fundamentals intact. Moving to Sell requires events that cut our target below $74.04, or a share rally above $93.19 without an earnings upgrade.

Exhibit 64: Seven dated milestones test cost pass-through and margins across the next 18 months
WindowCatalyst eventKey driverPenmark view vs Street / planValue stake / trigger
30 Nov 2026CFO Rouquet exit; interim CFO Myers assumes roleWarranty & CFOClean control handoff; permanent CFO search update without guidance revisionNeutral ($0/sh); governance watch
4Q26–1Q27Geely & SAIC China HPC production starts after CheryCockpit GoMPenmark +8.5% FY27E GoM; upside +1pt to +9.5% if domestic OEM mix accelerates~$0.92/sh FY27E ($0.68 DCF)
Feb 2027*4Q26 results, FY26 Form 10-K & initial FY27 guidanceCost recovery & marginPenmark $462.1m FY27E EBITDA (90% recov.) vs $494.8m Street & $520m plan; $0 extra warranty+$1.17 to −$2.19/sh (decisive test)
Feb 2027*Full-year FY26 new-business wins disclosureCockpit GoM$3.9bn won in 9M26; delayed DDR5 architecture awards test $6.0bn annual target+$1.60/sh on +1pt FY28–29 GoM
Apr–Jul 20271Q27 & 2Q27 prints: DRAM/PCB supply & OEM schedulesCustomer outputPenmark −1.0% FY27E customer output; H1 schedule cuts to −4.0% vs +1.0% rebound+$1.84 to −$2.76/sh
2H 2027Next-gen DDR5 cockpit sourcing & China Tier-1 biddingLong-run recoveryPenmark 100% pass-through by FY29E; risk OEMs cap long-run recovery at 90%−$8.33/sh (<$74.04 = Sell)
Feb 2028FY27 full-year underlying margin printMid-cycle marginTests 11.0% mid-cycle margin vs 12.0% structural durability or 10.3% reversion+$9.25 to −$6.72/sh (>$90.50 = Buy)

*Exact 4Q26 earnings release date unconfirmed by company; February 2027 timing reflects historical 10-K filing schedule (FY25 10-K filed 19 Feb 2026). Source: Penmark Research estimates.

Exhibit 65: Mid-cycle margin (+$9.25) and long-run recovery (−$8.33) drive the widest per-share swings
12.0% mid-cycle marginFY27 output +1.0%FY26 bookings hit $6bn98% FY27 cost recoveryChina HPC +1pt GoM+$20m warranty charge75% FY27 cost recoveryFY27 output −4.0%Revert to 10.3% margin90% long-run recovery+$9.25+$1.84+$1.60+$1.17+$0.92−$0.59−$2.19−$2.76−$6.72−$8.33

Source: Penmark Research estimates (single-driver value impacts vs $80.23 primary base value).

What upgrades Visteon to Buy (>$90.50 target)

Near-term cost recovery alone is not enough to upgrade the stock from today's price. Reaching Buy requires structural margin proof or a lower discount rate. Pairing near-full 2027 cost recovery with durable 12% mid-cycle margins would lift our target past $93 into Buy.

What downgrades Visteon to Sell (<$74.04 target)

Permanent carmaker pushback on memory cost resets is the fastest path to Sell. Guiding next year's adjusted EBITDA down near $388m would point to roughly 75% cost recovery. Structural 10% pass-through leakage or margin reversion toward 10% would then push our target below $74 into Sell.

Part IV: The Numbers · 17. Risks

Capped cost recovery (−$8.33) and margin reversion (−$6.72) lead per-share downside risks

Both downside and upside surprises can break our Hold rating because our target sits close to today's share price. Our 25% bear-case weight already pulls weighted present value below our base case. Permanent carmaker resistance to memory surcharges would push our target into Sell, whereas durable 12% mid-cycle margins would lift it into Buy.

Exhibit 66: Major downside risks reach −$8.33 per share while margin durability adds +$9.25
Risk factorProb.Value / shMechanism & filing evidenceThesis-breaking signpost
Capped long-run recovery25%−$8.33Chinese Tier-1 bidding & OEM software insourcing cap FY29E+ pass-through at 90% vs 100%DDR5 contract renewals embedding permanent 10% supplier absorption
Mid-cycle margin reversion35%−$6.72FY23–25 gains prove cyclical; underlying margin reverts to FY16–25's 10.3% meanEx-pass-through EBITDA margin slipping below 12.0% in FY27–28
Memory/PCB halts OEM lines35%−$2.76DDR4/high-layer PCB shortages cut FY27E customer output to −4.0% vs −1.0% base1H27 customer build schedules falling >3% y/y across major OEMs
FY27 surcharge pushback30%−$2.19OEMs fund only 75% of FY27E's $491.6m chip/PCB bill ($122.9m leakage vs $49.2m base)Feb 2027 FY27 Adjusted EBITDA guidance near ~$388m (75% recovery)
Extra warranty & CFO exit20%−$0.5910-Q flags up to $20m reasonably possible extra warranty charge; CFO exits 30 NovNew warranty provision in FY26 10-K or prolonged interim CFO tenure
Upside risk vs Hold: 12% margin & 98% recovery30% / 35%+$9.25 / +$1.17Platform reuse (~75% of CDC software) holds 12.0% mid-cycle margin while OEMs fund 98% of FY27 inflationFeb 2027 EBITDA guide ≥$500m & underlying margin holding ≥13.3%

Source: FY25 Form 10-K; Q3 FY26 Form 10-Q & call; October 2026 Form 8-K; Penmark Research estimates.

Exhibit 67: Bear-case shocks cut next year's adjusted EBITDA to $284.6m at a 7.0% margin
FY27E adj. EBITDAAdj. EBITDA margin (right)$0m$200m$400m$600m7%8%9%10%11%12%Bear caseBase caseBull case

Source: Penmark Research estimates ($284.6m bear, $462.1m base, $532.5m bull).

What would end our Hold thesis

Combining capped long-run pass-through with margin reversion would push our target into Sell. Sustaining underlying margins near 13% alongside near-full cost recovery would support a Buy upgrade instead. Governance and product quality affect equity value mainly through warranty containment and tariff exposure.

Contractual & customer concentration exposure

Ford, General Motors and Volkswagen generate nearly half of annual sales under purchase orders without minimum volume guarantees. Carmakers can delay cabin or electric-vehicle programmes or cancel orders for convenience. That contract structure shifts volume and fixed-cost risk onto Visteon.

Key-person, trade & product-quality risk

Finance chief Jerome Rouquet's late-November departure coincides with critical 2027 surcharge talks, with Colleen Myers serving as interim CFO. Cross-border manufacturing across Portugal, China and Mexico exposes margins to tariff shifts. Complex cabin electronics also carry warranty risk, underscored by $77m of third-quarter warranty charges across two distinct matters.

Part V: Appendix · 18. Ownership and trading

Short interest jumped 52% to 4.07m shares into Visteon's third-quarter reset

Visteon trades roughly $47m a day on Nasdaq with a single class of common shares. Positioning is split ahead of 2027 guidance as short interest climbed above five days to cover by late October. Over half of covering Street analysts still rate the stock Buy despite recent target cuts.

Exhibit 68: BlackRock and Vanguard lead 313 institutional filers in second-quarter Form 13F disclosures
Holder (Rank 1–6)2Q26 sh.q/q chg.*Holder (Rank 7–12)2Q26 sh.q/q chg.*
1. BlackRock3,579,723+25,9087. State Street1,143,022+48,715
2. Vanguard Group2,859,036+9,6808. Victory Capital808,692−309,475
3. American Century2,178,685−61,5169. Westwood Holdings806,071n/r*
4. T. Rowe Price1,962,483+139,76210. Geode Capital785,366+22,365
5. Dimensional Fund1,538,502+134,80711. Wellington Mgmt.772,648−146,499
6. Invesco1,143,718−141,19912. First Trust747,202+228,161
13F note: 313 filers reported 31,814,573 shares at 30 Jun 2026 vs 26,695,429 shares outstanding (23 Jul 2026); precise % ownership is omitted because 13F filings double-report shared-discretion and lent shares.

*q/q change compares 2Q26 (30 Jun 2026) vs 1Q26 (31 Mar 2026) top-20 13F extracts; n/r indicates holder outside top-20 1Q26 return (do not infer new entry or exit). Source: Signals Form 13F data.

Exhibit 69: Short interest climbed 52% to 4.07m shares between April and October
2.5m3.0m3.5m4.0m4.5mMay-26Jul-26Sep-264.1m

Source: Signals bi-weekly short interest through 30 Oct 2026 (5.4 days to cover vs 2.73 at 30 Jun).

Liquidity, short interest & buyback capacity

Elevated short interest represents more than five days of average daily trading volume, double June's level. Average daily turnover approached $48m over the past three months. Ongoing share repurchases under Visteon's remaining authorisation steadily absorb float ahead of February guidance.

Exhibit 70: Eight of 13 covering Street analysts still rate Visteon Buy
Buy (8)Hold (4)Sell (1)Street ratings841

Source: Consensus snapshot per MarketBeat and MarketScreener (15 Nov 2026).

Insider Form 4 activity & proxy stakes

Latest proxy disclosure from April 2026 shows insiders held 2.0% of shares, led by CEO Sachin Lawande at 1.6%. Two executives sold modest share blocks in June under pre-scheduled trading plans. Independent directors received routine annual equity grants the same month.

Street targets & trading technicals

Published Street targets span $95 to $135 around a mean near $112. Several brokers including Barclays, UBS and RBC Capital Markets cut their targets over the past quarter, while short positioning and buyback capacity could amplify event-day moves.

What positioning means for our Hold call: Visteon pairs elevated short interest with a bullish Street consensus and remaining buyback capacity equal to nearly a third of market value. Guiding to near-full cost recovery next year could squeeze shares toward our bull case. Sub-85% recovery guidance would pressure remaining triple-digit Street targets instead.
Part V: Appendix · 19. Financial model

Annual sales climb from $3,768m to $5,842m across our ten-year forecast

Exhibit 71: Annual adjusted EBITDA troughs at $386m before climbing to a $619m peak
$m (except per-share & ratios)FY25AFY26EFY27EFY28EFY29EFY30EFY35E
Income statement & per-share metrics
Net sales3,7683,8244,3754,6264,9035,1225,842
Company-defined Adjusted EBITDA492386462537612619590
Adjusted EBITDA margin (%)13.1%10.1%10.6%11.6%12.5%12.1%10.1%
D&A / SBC / Restructuring & other(171)(198)(194)(197)(205)(249)(285)
Operating income (GAAP EBIT)321188268340407370304
Profit before tax / Income tax338 / (125)202 / (63)275 / (77)345 / (97)412 / (115)376 / (105)313 / (88)
Net income attributable to Visteon201133189237283259215
Diluted EPS / Adjusted EPS ($)*7.28 / 7.745.07 / 5.937.73 / 8.0410.58 / 10.7414.11 / 14.3014.58 / 16.34n/m*
Shares (m) / dividends per share (DPS) ($)*27.6 / 0.5526.2 / 1.5024.4 / 1.5622.4 / 1.6220.1 / 1.6917.7 / 1.75n/m*
Condensed balance sheet, cash flow & return ratios
Cash & restr. cash / Total debt773 / 301549 / 326436 / 311421 / 296406 / 281391 / 266391 / 266
Trade working capital / PP&E & intangibles342 / 746356 / 811429 / 839439 / 867466 / 895487 / 920555 / 1,059
Visteon shareholders' equity / Net cash1,568 / 4721,464 / 2231,514 / 1251,567 / 1251,619 / 1251,667 / 1251,876 / 125
Operating cash flow / Capex410 / (133)224 / (150)259 / (158)413 / (162)470 / (167)457 / (169)450 / (193)
GAAP FCF / Adjusted FCF277 / 29274 / 100101 / 111251 / 256304 / 309288 / 330257 / 304
Share repurchases ($m)(57)(236)(155)(205)(258)(243)(227)
ROE / ROCE / Net debt to Adj. EBITDA12.8 / 19.6 / −1.0x9.1 / 10.2 / −0.6x12.5 / 13.0 / −0.3x15.1 / 16.0 / −0.2x17.5 / 18.5 / −0.2x15.5 / 16.3 / −0.2x11.5 / 11.9 / −0.2x

*FY35E per-share figures omitted because a mechanical $125m net-cash sweep dominates terminal share count. Source: FY25 Form 10-K; Penmark Research estimates (cash includes $2m restricted cash).

Exhibit 72: Quarterly adjusted EBITDA rebounds to $120m after $77m of third-quarter warranty charges
$m (except % KPIs)1Q25A2Q25A3Q25A4Q25A1Q26A2Q26A3Q26A4Q26E
Product-line sales disaggregation (single Electronics reportable segment)
Instrument clusters435451421440475447445n/m
Information displays122126117135148161167n/m
Audio and infotainment125140131112116127122n/m
Cockpit domain controllers (CDC/HPC)1171119610494103104n/m
Body & electrification / Other (incl. HUD)98 / 37102 / 39111 / 41109 / 4876 / 4575 / 4781 / 51n/m
Total Net sales934969917948954960970940
Quarterly profitability & operating KPIs
Adjusted EBITDA (reported)12913411911010411646*120
Adjusted EBITDA margin (%)13.8%13.8%13.0%11.6%10.9%12.1%4.7%*12.8%
Growth over Market / Customer output+10% / n/r−1% / n/r−5% / n/r+7% / n/r+3% / −4%+4% / −5%+10% / −5%MSD* / ~−6%

*3Q26A adjusted EBITDA includes $77m of warranty charges ($123m or 12.7% excluding them); 4Q26E growth over market reflects mid-single-digit (MSD) guidance. Source: Company filings; Penmark Research estimates.

Part V: Appendix · 20. Reference

Reconciliations bridge GAAP net income to $492m of reported adjusted EBITDA and $462.1m next year

Exhibit 73: Non-cash stock pay and restructuring bridge $201m GAAP profit to $492m adjusted EBITDA
$m (except per-share $)FY22AFY23AFY24AFY25AFY26EFY27EFY28E
GAAP net income to company-defined Adjusted EBITDA & normalized EBITDA
GAAP net income attributable to Visteon*124568296201133.1188.8237.2
Net income attributable to NCI / Tax / Net int.61(304)012866.388.9113.4
Less: Equity in net income of affiliates1103(8)(11.0)(10.0)(10.3)
Depreciation and amortisation10810496109120.8129.8134.2
Non-cash SBC / Restructuring & other items5456796276.864.762.8
Company-defined Adjusted EBITDA348434474492386.0462.1537.3
Memo: Standardized reported EBITDA (Signals)n/dn/d364448n/mn/mn/m
GAAP EPS to Adjusted EPS & GAAP FCF to Adjusted FCF
GAAP Diluted EPS / Adjusted EPS ($)n/r / n/rn/r / n/r10.61* / n/r7.28 / 7.745.07 / 5.937.73 / 8.0410.58 / 10.74
GAAP OCF / Less capital expenditure167 / (81)267 / (125)427 / (137)410 / (133)224 / (150)259 / (158)413 / (162)
GAAP FCF / Plus restr. cash = Adjusted FCF86 / 101142 / 150290 / 300277 / 29274 / 100101 / 111251 / 256

*Prior GAAP net income restated for the 2025 DTA method change ($9.82 pre-restatement FY24A diluted EPS on $274m net income; $10.61 restated). Source: Company filings; Penmark Research estimates.

Glossary of company & sector terms

CDC and HPC: Cabin computers running multiple operating systems on one chip to combine clusters, infotainment and displays, using Visteon's SmartCore software and CognitoAI voice assistant.

DDR4, DDR5 and PCB pass-through: Industry shift from end-of-life DDR4 memory to costlier DDR5 chips and multi-layer circuit boards, driving nearly $500m of 2027 cost inflation.

Growth over Market and CPV: Organic sales growth excluding currency and pricing minus customer-weighted car production growth, lifted by cabin content rising from $125 up to $1,000.

Ratio definitions & peer set

Underlying vs normalised EBITDA: Underlying EBITDA strips out zero-margin chip recoveries and exceptional warranty charges. Normalised EBITDA deducts trailing SBC and normal ten-year restructuring to match peer GAAP-reported EBITDA.

Returns and EV bridge: ROE divides net income by ending equity, while ROCE divides after-tax EBIT by invested capital. Our EV bridge adds debt, joint-venture minority claims, pensions and after-tax warranty accruals, less cash and affiliate stakes.

Peer set: Gentex, Autoliv, Lear, PHINIA and Adient set our peer-median multiple, while BorgWarner, Aptiv and Magna are excluded on impairments, spin-offs or IFRS differences.

Methodology note & known limits

Business type: Products and units automotive electronics supplier reporting in US dollars on Nasdaq, valued on cyclical mid-cycle earnings. Product and regional maps replace sum-of-the-parts analysis because Visteon reports one Electronics segment, and tax swings rule out P/E as our primary method.

Known limits: Peer multiples use trailing reported EBITDA, and trailing underlying sales deduct our estimated 2026 cost-recovery share. Third-quarter warranty charges are treated as unpaid at September, and our equity risk premium uses Damodaran's May 2026 estimate.

Data sources & cut-off dates

Market and estimate cut-off: Data as of 13 Nov 2026, covering Visteon's closing share price, peer prices, ten-year US Treasury yields and Yahoo Finance return series.

Filings and snapshots: Sources include the FY25 Form 10-K (February 2026), Form DEF 14A proxy statement (April 2026), Investor Day presentation (June 2026) and third-quarter Form 10-Q and call (October 2026). Governance and positioning also use October's Form 8-K, Signals Form 13F and short-interest series, and MarketScreener and MarketBeat consensus snapshots.

Part V · Appendix · 21. Disclosures

Analyst certification and important disclosures

Ratings

Ratings are based on the upside from the share price to our 12-month price target, excluding dividends. The price target is weighted across bull, base and bear scenarios.

BuyUpside to price target above +10%
HoldUpside to price target from −10% to +10%, inclusive
SellUpside to price target below −10%

We review ratings at each set of results and whenever the facts change materially. A share price can move outside its band before the rating changes, and targets may not be reached.

Analyst certification

The Penmark Research Team certifies that (1) the views in this report accurately reflect its views about the subject company and its securities, and (2) no part of its compensation was, is or will be directly or indirectly related to the specific ratings, price targets or views in this report.

Contact

Penmark Research

Questions about our research:
research@penmarkresearch.com

All our research and coverage:
penmarkresearch.com

Basis of preparation

This report uses information publicly available up to its publication date. Share prices are closing prices on the trading day before the publication date, unless stated otherwise. Forecasts, valuations and price targets are Penmark Research’s own, and forecast periods are marked E. Sources are shown beneath each exhibit.

Valuation and price targets

Price targets are based on the valuation methods set out in each report and are weighted across bull, base and bear scenarios. The main risks to each rating and price target are described in the report. Penmark Research updates its coverage after each set of results but is not obliged to update a report at any other time.

Independence and conflicts of interest

Penmark Research is independent. It does not provide investment banking, brokerage, market-making or asset management services, does not trade securities, and does not accept payment from any company for research coverage. Companies do not see or review Penmark Research reports before publication.

No member of the Penmark Research Team holds a long or short position, directly or through derivatives, in the securities of any company Penmark Research covers.

Regulatory status

Penmark Research publishes general, impersonal investment research on a regular basis. It is not registered as an investment adviser with the US Securities and Exchange Commission or any state securities authority, is not a registered broker-dealer and is not a member of FINRA. Penmark Research does not give advice tailored to any person’s circumstances.

Not investment advice or an offer

This report is for information only. It is not personalised investment advice and is not an offer or solicitation to buy or sell any security or other financial instrument. It does not take into account any reader’s objectives, financial situation or needs. Readers should make their own investment decisions and seek independent professional advice where appropriate.

Forward-looking statements and risk

Forecasts, valuations and price targets are estimates based on assumptions that may prove wrong, and they may not be achieved. Opinions are current as of the publication date and may change without notice. Investing in equities involves risk, including the loss of capital. Share prices can be volatile, and past performance is not a reliable indicator of future results.

Data and sources

Company financials, operating data and filings come from company filings, earnings releases and earnings calls. Market data and any consensus estimates come from third-party sources named beneath the relevant exhibit; consensus figures from aggregators are unofficial. Penmark Research does not use other brokers’ research. Third-party data belong to their providers and may not be extracted from this report.

Accuracy and liability

Information is taken from sources believed to be reliable, but Penmark Research makes no representation or warranty as to its accuracy, completeness or timeliness. To the fullest extent permitted by law, Penmark Research accepts no liability for any loss arising from use of this report. Descriptions of litigation and regulatory matters reflect allegations and public records, not findings, unless stated. If a published report is corrected, the corrected version carries an “Updated” date at penmarkresearch.com.

Distribution and access

Penmark Research reports are available to registered users of penmarkresearch.com. Downloads and programmatic access are governed by the Penmark Research subscription terms. This report is not directed at, or intended for, any person in Singapore or India, and access from those countries is blocked. It is not intended for distribution to, or use by, any person in any jurisdiction where that would be contrary to law or regulation or would subject Penmark Research to registration or licensing requirements there.

Copyright and permitted use

© Penmark Research. All rights reserved. Penmark Research is a trade name of Brightriver Labs. Readers may share a link to this report but may not copy, reproduce, redistribute, sell or use its content, including for text and data mining, without written consent. Contact: research@penmarkresearch.com.

Keep reading

Sign in to Penmark